NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

.10 share price with 2.7B outstanding shares would give the company a $270M market cap. Thats going to be a rich valuation without NICE reimbursement and FDA BLA submission. Without NICE approval, they wont exceed $10-15M annual revenue. At a generous 6X revenue, you are looking at under $100M market cap in that case. So, a share price of under .05 is likely in the first half of 2027, if not sooner.